Cargando…
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563904/ https://www.ncbi.nlm.nih.gov/pubmed/28826397 http://dx.doi.org/10.1186/s12931-017-0638-2 |
| _version_ | 1783258180580540416 |
|---|---|
| author | Reisner, Colin Fabbri, Leonardo M. Kerwin, Edward M. Fogarty, Charles Spangenthal, Selwyn Rabe, Klaus F. Ferguson, Gary T. Martinez, Fernando J. Donohue, James F. Darken, Patrick St. Rose, Earl Orevillo, Chad Strom, Shannon Fischer, Tracy Golden, Michael Dwivedi, Sarvajna |
| author_facet | Reisner, Colin Fabbri, Leonardo M. Kerwin, Edward M. Fogarty, Charles Spangenthal, Selwyn Rabe, Klaus F. Ferguson, Gary T. Martinez, Fernando J. Donohue, James F. Darken, Patrick St. Rose, Earl Orevillo, Chad Strom, Shannon Fischer, Tracy Golden, Michael Dwivedi, Sarvajna |
| author_sort | Reisner, Colin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5563904 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55639042017-08-23 Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease Reisner, Colin Fabbri, Leonardo M. Kerwin, Edward M. Fogarty, Charles Spangenthal, Selwyn Rabe, Klaus F. Ferguson, Gary T. Martinez, Fernando J. Donohue, James F. Darken, Patrick St. Rose, Earl Orevillo, Chad Strom, Shannon Fischer, Tracy Golden, Michael Dwivedi, Sarvajna Respir Res Erratum BioMed Central 2017-08-21 2017 /pmc/articles/PMC5563904/ /pubmed/28826397 http://dx.doi.org/10.1186/s12931-017-0638-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Erratum Reisner, Colin Fabbri, Leonardo M. Kerwin, Edward M. Fogarty, Charles Spangenthal, Selwyn Rabe, Klaus F. Ferguson, Gary T. Martinez, Fernando J. Donohue, James F. Darken, Patrick St. Rose, Earl Orevillo, Chad Strom, Shannon Fischer, Tracy Golden, Michael Dwivedi, Sarvajna Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease |
| title | Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease |
| title_full | Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease |
| title_fullStr | Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease |
| title_full_unstemmed | Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease |
| title_short | Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease |
| title_sort | erratum to: a randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel co-suspension™ delivery technology in patients with moderate-to-very severe chronic obstructive pulmonary disease |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563904/ https://www.ncbi.nlm.nih.gov/pubmed/28826397 http://dx.doi.org/10.1186/s12931-017-0638-2 |
| work_keys_str_mv | AT reisnercolin erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT fabbrileonardom erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT kerwinedwardm erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT fogartycharles erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT spangenthalselwyn erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT rabeklausf erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT fergusongaryt erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT martinezfernandoj erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT donohuejamesf erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT darkenpatrick erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT stroseearl erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT orevillochad erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT stromshannon erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT fischertracy erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT goldenmichael erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease AT dwivedisarvajna erratumtoarandomizedsevendaystudytoassesstheefficacyandsafetyofaglycopyrrolateformoterolfumaratefixeddosecombinationmetereddoseinhalerusingnovelcosuspensiondeliverytechnologyinpatientswithmoderatetoveryseverechronicobstructivepulmonarydisease |